Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort.

Thein HH, Walter SR, Gidding HF, Amin J, Law MG, George J, Dore GJ.

Hepatol Res. 2012 Dec;42(12):1175-86. doi: 10.1111/j.1872-034X.2012.01037.x.

PMID:
22607544
2.

Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.

Nguyen VT, Amin J, Law MG, Dore GJ.

J Gastroenterol Hepatol. 2009 Mar;24(3):436-42. doi: 10.1111/j.1440-1746.2008.05577.x.

PMID:
19175834
3.

Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.

Makarova M, Krettek A, Valkov MY, Grjibovski AM.

Int J Circumpolar Health. 2013 May 13;72:20282. doi: 10.3402/ijch.v72i0.20282.

4.

Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.

Walter SR, Thein HH, Gidding HF, Amin J, Law MG, George J, Dore GJ.

J Gastroenterol Hepatol. 2011 Dec;26(12):1757-64. doi: 10.1111/j.1440-1746.2011.06785.x.

PMID:
21615789
5.

Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.

Thein HH, Walter SR, Gidding HF, Amin J, Law MG, George J, Dore GJ.

J Viral Hepat. 2011 Jul;18(7):e232-41. doi: 10.1111/j.1365-2893.2011.01440.x.

PMID:
21692938
6.
7.
8.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

9.

Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).

Waziry R, Grebely J, Amin J, Alavi M, Hajarizadeh B, George J, Matthews GV, Law M, Dore GJ.

J Hepatol. 2016 Dec;65(6):1086-1093. doi: 10.1016/j.jhep.2016.08.010.

PMID:
27569777
10.

Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009.

Jembere N, Campitelli MA, Sherman M, Feld JJ, Lou W, Peacock S, Yoshida E, Krahn MD, Earle C, Thein HH.

PLoS One. 2012;7(7):e40917. doi: 10.1371/journal.pone.0040917.

11.

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.

BMC Cancer. 2012 Oct 5;12:452. doi: 10.1186/1471-2407-12-452.

12.

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.

Merchante N, Merino E, López-Aldeguer J, Jover F, Delgado-Fernández M, Galindo MJ, Ortega E, Rivero A, Mínguez C, Romero-Palacios A, Padilla S, Márquez-Solero M, Amador C, Ríos-Villegas MJ, Téllez F, Portilla J, Pineda JA.

Clin Infect Dis. 2013 Jan;56(1):143-50. doi: 10.1093/cid/cis777.

13.

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.

Cancer. 1999 May 15;85(10):2132-7.

PMID:
10326690
14.

Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma.

Tanase AM, Dumitrascu T, Dima S, Grigorie R, Marchio A, Pineau P, Popescu I.

Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):162-72.

15.

Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.

Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.

J Gastroenterol Hepatol. 2011 Sep;26(9):1380-8. doi: 10.1111/j.1440-1746.2011.06776.x.

PMID:
21884247
16.

Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.

Walter SR, Thein HH, Amin J, Gidding HF, Ward K, Law MG, George J, Dore GJ.

J Hepatol. 2011 May;54(5):879-86. doi: 10.1016/j.jhep.2010.08.035.

PMID:
21145812
17.

Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN.

J Gastroenterol. 2010 Jun;45(6):636-45. doi: 10.1007/s00535-009-0189-5.

PMID:
20054698
18.

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ; REVEAL-HBV Study Group..

J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243.

19.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

20.

Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.

Amin J, O'Connell D, Bartlett M, Tracey E, Kaldor J, Law M, Dore G.

Aust N Z J Public Health. 2007 Oct;31(5):475-82.

PMID:
17931297
Items per page

Supplemental Content

Support Center